Prevalence and associated risk factors of peripheral artery disease in virologically suppressed HIV-infected individuals on antiretroviral therapy in Kwara state, Nigeria: a cross sectional study

Table 6 Results of logistic regression analysis: association of risk factors with low ankle-brachial index value in the study group

Parameter	OR	95% CI	P-value
BMI	1.052	0.971–1.138	0.214
Age	0.993	0.942–1.046	0.703
WC	1.040	1.000–1.082	0.052
WHR	1.126	0.409–3.107	0.818
CD4+ T cell ≥500 cells/mm³	1.000	0.999–1.002	0.801
CD4+ T cell < 200 cells/mm³	2.635	0.327–21.05	0.364
Duration of HIV	1.060	0.929–1.210	0.385
Duration on ART	1.094	0.952–1.258	0.203
FPG	0.978	0.546–1.753	0.941
TC	1.784	1.142–2.787	0.011*
TG	6.440	0.269–154.26	0.250
HDL-C	0.215	0.000–208.20	0.215
LDL-C	1.824	1.155–2.880	0.010*
Hypertension	2.115	0.460–9.716	0.335
Family history of CVD	0.956	0.197–4.642	0.956
MetS based on IDF	1.051	0.324–3.408	0.935
Protease inhibitor (LPV/r)	0.678	0.134–3.43	0.638
Hypertension	2.115	0.461–9.716	0.335
Diabetes mellitus	0.328	0.056–1.910	0.215
Viral load ≥20 copies/ml	1.375	0.532–3.55	0.511

* = significant at P < 0.05. CI Confidence interval, OR Odd ratio, TC Total cholesterol, TG Triglyceride, BMI Body mass index, FPG Fasting plasma glucose, WC Waist circumference, WHR Waist hip ratio, HDL High-density lipoprotein LDL Low-density lipoprotein, LPV/r Lopinavir/ritonavir

ISSN: 1471-2458